Public Reporting

Accountable Care Public Reporting Information

Accountable Care Organization (ACO) Name and Location

Freedom Healthcare Alliance, LLC
8761 Dorchester Road
Suite 230
North Charleston, SC 29420

ACO Primary Contact
Primary Contact Name: Lissa Lara, CEO
Primary Contact Phone Number: 843-412-1590
Primary Contact Email Address: lissalara@qualityhealthcaredevelopment.com

Organizational Information

ACO PARTICIPANTS ACO PARTICIPANT IN JOINT-VENTURE (Enter Y or N)
Internal Medicine of Walterboro N
James T Martin Jr, MD N
Lake City Family Medicine, LLC N
Liberty Doctors, LLC N
Coastal Internal Medicine & Geriatrics N
Walterboro Adult & Pediatric Medicine N

ACO Governing Body

Member First Name Member Last Name Title/Position Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Lissa Lara CEO 16% Other N/A
Hugh Durrence MD CMO Board Member 13% ACO Participant Representative Liberty Doctors, LLC
Donald Hanna MD Board Member 13% ACO Participant Representative Liberty Doctors, LLC
Douglas Gleaton MD Board Member 13% ACO Participant Representative Liberty Doctors, LLC
John Forney MD Board Member 13% ACO Participant Representative Liberty Doctors, LLC
David Price MD Board Member 6% Medicare Beneficiary Representative N/A
James Martin Jr MD Board Member 13% ACO Participant Representative James T Martin Jr., LLC
Jeffrey Kramer MD Board Member 13% ACO Participant Representative Internal Medicine of Walterboro

KEY ACO CLINICAL AND ADMINISTRATIVE LEADERSHIP:

Lissa Lara ACO Executive
Hugh Durrence Medical Director
John Park Compliance Officer
Kathrine Hill Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Finance Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
Quality Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
Kathrine Hill, Quality Assurance, Improvement Officer
Compliance Committee Lissa Lara, CEO
Hugh Durence, RPh, MD, Medical Director
John Park, Compliance Officer

4Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • Primary Care Practice
  • OBGYN

Shared Savings and Losses

Amount of Shared Savings/Losses:

    • Fifth Agreement Period
      • Performance Year 2023, $3,583,436.00
    • Fourth Agreement Period
      • Performance Year 2022, $3,429,097.03
    • Third Agreement Period
      • Performance Year 2021, $2,563,470.56
    • Second Agreement Period
      • Performance Year 2020, $2,960,193.32
    • First Agreement Period
      • Performance Year 2019, $921,888.00

Shared Savings Distribution:

Fifth Agreement Period : Performance Year 2023

    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 4%
    • Proportion of distribution to ACO participants: 76%

Fourth Agreement Period : Performance Year 2022

    • Proportion invested in infrastructure: 5%
    • Proportion invested in redesigned care processes/resources: 6%
    • Proportion of distribution to ACO participants: 5%

Third Agreement Period : Performance Year 2021

    • Proportion invested in infrastructure: 16%
    • Proportion invested in redesigned care processes/resources: 9%
    • Proportion of distribution to ACO participants: 74%

Second Agreement Period : Performance Year 2020

    • Proportion invested in infrastructure: 30%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 60%

First Agreement Period : Performance Year 2019

    • Proportion invested in infrastructure: 37%
    • Proportion invested in redesigned care processes/resources: 10%
    • Proportion of distribution to ACO participants: 53%

Quality Performance Results

2023 Quality Performance Results:

Quality performance results are based on the CMS Web Interface collection type.

 

Measure #

Measure Name

Collection Type

Reported Performance Rate

Current Year Mean Performance Rate (SSP ACOs)

Quality ID# 321  

CAHPS for MIPS

CAHPS for MIPS Survey

6.87

6.25

Measure# 479

Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups

Administrative Claims

0.1631

0.1553

Measure# 484

Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC)

Administrative Claims

N/A

35.39

Quality ID# 318

Falls: Screening for Future Fall Risk

CMS Web Interface

94.99

89.42

Quality ID# 226

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS Web Interface

62.22

79.29

Quality ID# 113

Colorectal Cancer Screening

CMS Web Interface

59.62

77.14

Quality ID# 112

Breast Cancer Screening

CMS Web Interface

71.01

80.36

Quality ID# 438

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS Web Interface

80.80

87.05

Quality ID# 370

Depression Remission at Twelve Months

CMS Web Interface

26.32

16.58

Quality ID# 001

Diabetes: Hemoglobin A1c  (HbA1c) Poor Control

CMS Web Interface

13.57

9.84

Quality ID# 134

Preventive Care and Screening: Screening for Depression and Follow-up Plan

CMS Web Interface

80.22

80.97

Quality ID# 236

Controlling High Blood Pressure

CMS Web Interface

74.91

77.80

For previous years’ Financial and Quality Performance Results, please visit: data.cms.gov

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
  • Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

 Fraud and Abuse Waivers

        ACO Participation Waiver:
          The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.
            • Parties to the arrangement: Freedom Health Alliance, LLC and Laboratory Corporation of America Holdings
            • Date of arrangement: 12/1/2022
            • Items, services, goods, or facility provided: Grants to incorporate data analytics platforms to facilitate care coordination and promote outcomes of care. Incorporate Lab Corp’s lab data into clinical data to provide a more robust view of the ACO’s patient population.
            • Date and nature of any amendments to the arrangement,: January 1, 2024 – December 31, 2024, Renewal Agreement.